Table 1.

Baseline characteristics of men and women in the study population (Multi-Ethnic Study of Atherosclerosis baseline examination 1998–2000)

		Men	Women	p
N at baseline		3144	2038
Data available from both follow-up visits		2708 (86.1%)	1678 (82.3%)
Follow-up data available from only one visit		246 (7.8%)	178 (8.7%)
No follow-up data available		190 (6.0%)	182 (8.9%)
Age (years)		62.2±10.2	65.6±9.2	<0.001
Race/Ethnicity
White		39.3%	30.3%	<0.001
Chinese		12.3%	13.5%
Black		25.7%	31.0%
Hispanic		22.7%	25.2%
		Cardiovascular Risk Factors
Systolic BP (mmHg)		125.9±19.3	130.7±23.9	<0.001
Diastolic BP (mmHg)		75.0±9.4	69.6±10.4	<0.001
Diabetes (%)		15.5%	15.8%	0.764
Current Smokers (%)		14.3%	10.6%	<0.001
Current Alcohol users (%)		62.6%	42.4%	<0.001
BP medication use (%)		30.5%	38.5%	<0.001
Lipid medication use (%)		17.6%	20.6%	0.008
		Biochemical assays (mg/dL)
Fasting Plasma Glucose		107.2±33.5	105.3±29.7	0.034
Serum Total Cholesterol		188±35	203±37	<0.001
Serum LDL Cholesterol		117±31	122±32	<0.001
Serum HDL Cholesterol		45.0±11.8	54.5±14.4	<0.001
Serum Triglycerides		113 [79 to 166]	110 [77 to 157]	0.026
Serum Insulin (µU/mL)		5.4 [3.5 to 8.5]	5.8 [3.9 to 8.8]	<0.001
		Anthropometry
BMI (kg/m2)		27.9±4.5	29.0±6.1	<0.001
Waist Girth (cm)		99.3±12.2	98.6±15.5	0.094
Waist-Hip Ratio (%)		95.8±6.6%	91.7±8.0%	<0.001
		Sex Hormone variables
Total Testosterone (nmol/L)		14.2 [11.4 to 17.8]	0.97 [0.62 to 1.39]	<0.001
Bioavailable Testosterone (nmol/L)		5.2 [4.2 to 6.5]	0.24 [0.17 to 0.38]	<0.001
Estradiol (nmol/L)		0.114 [0.088 to 0.140]	0.059 [0.040 to 0.084]	<0.001
DHEA (nmol/L)		12.5 [9.1 to 17.1]	11.0 [7.5 to 15.3]	<0.001
SHBG (nmol/L)		40.8 [31.4 to 52.7]	50.3 [36.7 to 69.9]	<0.001